PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, February 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 58 Dimensions

Readers on

mendeley: 106 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 2,387 followers.

Poly(ADP-ribose) polymerase inhibitors #PARPinhibitors in #platinumsensitive high-grade serous #HGSOC #ovariancancer https://t.co/QRYstFIByr #ChristieResearchers @OncologyMedical @TheChristieNHS @TheChristieSoO #chemotherapy #Gynaecological #Oncology #BRCA

Reply Repost Favourite

RT @cancerSL: PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer. https://t.co/IHFQFNWg6G

Reply Repost Favourite

PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer. https://t.co/IHFQFNWg6G

Reply Repost Favourite

PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer. https://t.co/3dllgofpQ7

Reply Repost Favourite